Health

Corona Virus Medicine: India’s new weapon on Corona, soon Made in India ‘Molnupiravir’ drug will get approval. 1 News Track English

Corona Virus Medicine: Now the country is going to get a new weapon in India’s fight against Coronavirus. Molnupiravir, an early drug among anti-corona vaccines, may also be approved. This medicine is Made in India. President Dr. Ram Vishwakarma, President of the Kovid Strategy Group, said that permission can be obtained within ‘a few days’. This drug will be useful for people with mild to moderate Kovid infected. However it will not be for children. He said that some other pharmaceutical companies, including Pfizer, have also applied. He said, ‘Two medicines will make a difference. As we move from epidemic to endemic, these drugs will be more important than vaccination.

Vishwakarma (President Dr. Ram Vishwakarma) said, ‘I think Molnupiravir will already be available for us. Five companies are in talks with the drugmaker. I think the approval will be given any day. He said that regulatory bodies have data on Molnupiravir for approval in the UK. Along with this, the Subject Expert Committee in India is also looking into this. I believe now they will get approval faster. In such a situation, it is fair to say that a decision will be taken on the approval of this drug in the next one month.

He said- ‘I think when the Indian government will buy medicines in bulk from these companies. Initially, it may cost ‘2000 to 3000 or 4000 rupees per treatment cycle. After that the prices will come down to Rs 500 to 600 or Rs 1,000. He said that I think Molnupiravir will be available soon. There are five such companies that are working closely with the drug manufacturer. I think that in such a situation, we can get permission to use it at any time. At the same time, Pfizer said in a statement that their drug Paxlovid reduces the risk of hospitalization or death in vulnerable patients by 89 percent.

pfizer is also making medicine

Let us tell you that Pfizer is also working on one such drug. Pfizer started manufacturing this drug named PF-07321332 in March 2020, it is being tested in combination with Ritonavir (HIV medicine). This drug is called a protease inhibitor, according to laboratory tests, this drug jams the replication machinery of the virus, that is, its doubling mechanism.

If this drug works in the same way in real life, then it will be possible to stop the infection at an early stage. By now covid takes the form of a serious disease. Merck has already contracted with five companies and just as Merck has licensed this to several companies, Pfizer will do the same as Pfizer will have to use Indian capacity to manufacture essential drugs for global use. .

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
error: Content is protected !!